Research News and Research

RSS

Bielefeld neuroscientists present a new bodily illusion

To induce an illusory perception of the material properties of the hand, a group of neuroscientists from Bielefeld University, the Max-Planck Institute for Biological Cybernetics (Germany), and the University of Milano-Bicocca (Italy) asked volunteers to sit with their hands lying on a table in front of them.

25 Mar 2014

Researchers exploit plasmonic nanoparticles to kill tumour cells

If you put your hand over a switched-on torch in the dark, it appears to glow red. This is because long-wavelength red light beams penetrate human tissue more effectively than short-wavelength blue light.

25 Mar 2014

Research findings underscore importance of mice as reservoirs for tick-borne pathogens

People living in northern and central parts of the U.S. are more likely to contract Lyme disease and other tick-borne ailments when white-footed mice are abundant. Mice are effective at transferring disease-causing pathogens to feeding ticks. And, according to an in-press paper in the journal Ecology, these "super hosts" appear indifferent to larval tick infestations.

25 Mar 2014

XBP1 gene plays pivotal role in the growth and progression of triple negative breast cancer

Scientists from Weill Cornell Medical College and Houston Methodist have found that a gene previously unassociated with breast cancer plays a pivotal role in the growth and progression of the triple negative form of the disease, a particularly deadly strain that often has few treatment options. Their research, published in this week's Nature, suggests that targeting the gene may be a new approach to treating the disease.

25 Mar 2014

Democratic lawmakers ask hepatitis C drugmaker to justify price

A new drug to treat hepatitis C that costs $1,000 a pill has caused rising concern among insurers and state Medicaid programs. It has now also spurred interest from Democratic congressmen whose queries about the drug prompted a sell-off in biotechnology stocks on Friday. Three Democratic members of the House Energy and Commerce Committee have demanded that Gilead Sciences, the developer, justify the price of its drug, which is called Sovaldi (Pollack, 3/21).

25 Mar 2014

New subcellular mechanism identified for fast transmission in basket cells of the brain

In his third major research paper since December 2013, IST Austria Professor Peter Jonas together with his collaborator, postdoc Hua Hu, identifies a new subcellular mechanism for reliable, fast transmission in the so-called basket cells of the brain.

25 Mar 2014

Supreme Court to hear health law contraceptive case on Tuesday

At issue is whether for-profit companies, such as Hobby Lobby, are entitled to the same religious protections as individuals or religious organizations.

25 Mar 2014

Transgene raises €65.5M via two-step capital increase

Transgene SA, a French biopharmaceutical company focused on discovering, developing and manufacturing targeted immunotherapies for the treatment of cancer and infectious diseases, announces that it has raised a total of €65.5 million via a two-step capital increase.

25 Mar 2014

Provo-Orem, Utah ranked first in Gallup-Healthways Community Well-Being Index

For the sixth consecutive year, global well-being improvement leader Healthways (NASDAQ: HWAY) and world-leading management consulting firm Gallup have released their analysis of the state of well-being for communities, states and congressional districts in the United States.

25 Mar 2014

Viewpoints on challenge to contraceptive coverage mandate

This week, the owners of two secular, for-profit corporations will ask the Supreme Court to take a radical turn and allow them to impose their religious views on their employees - by refusing to permit them contraceptive coverage as required under the Affordable Care Act. The Supreme Court has consistently resisted claims for religious exemptions from laws that are neutral and apply broadly when the exemptions would significantly harm other people, as this one would. To approve it would flout the First Amendment, which forbids government from favoring one religion over another - or over nonbelievers (3/22).

25 Mar 2014

NeuroVive Pharmaceutical initiates research collaboration with A1M Pharma

NeuroVive Pharmaceutical AB (publ) and A1M Pharma AB (publ) have announced that the two companies are initiating a research collaboration in mitochondrial medicine. The partnership is governed by a collaboration agreement signed on 21 March 2014.

25 Mar 2014

Agios initiates AG-120 Phase 1 study to evaluate advanced solid tumors with IDH1 mutation

Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and inborn errors of metabolism, today announced dose administration for the first patient in a Phase 1 study of AG-120 in patients with advanced solid tumors with an isocitrate dehydrogenase-1 (IDH1) mutation.

25 Mar 2014

New technology gives tool to examine membrane proteins in natural environment of human cell

Scientists have a better way to study human proteins - large molecules that are part of every cell in the body - thanks to a new technology developed by University of Toronto researchers.

25 Mar 2014

Low dose injections of artificial properdin provide protection against septic diseases

Researchers at the University of Leicester have produced an artificial version of a naturally occurring protein, properdin, which has been found to successfully combat bacterial pneumonia and meningitis when tested in mice.

25 Mar 2014

Scientists develop new method to deliver cancer-fighting drugs directly to milk ducts

One of every eight women in the United States will develop breast cancer. Though the incidence of breast cancer began decreasing in 2000, it is still the second-leading cause of cancer death in women.

25 Mar 2014

UC receives grant to better understand how "microparticles" in blood contribute to inflammation, injury

A University of Cincinnati (UC) trauma and critical care researcher has received a National Institutes of Health grant to better understand how "microparticles" in stored blood can contribute to inflammation and injury after resuscitation from traumatic injury.

25 Mar 2014

Research News and Research

Bielefeld neuroscientists present a new bodily illusion

Researchers exploit plasmonic nanoparticles to kill tumour cells

Research findings underscore importance of mice as reservoirs for tick-borne pathogens

XBP1 gene plays pivotal role in the growth and progression of triple negative breast cancer

Democratic lawmakers ask hepatitis C drugmaker to justify price

New subcellular mechanism identified for fast transmission in basket cells of the brain

Supreme Court to hear health law contraceptive case on Tuesday

Transgene raises €65.5M via two-step capital increase

Provo-Orem, Utah ranked first in Gallup-Healthways Community Well-Being Index

Viewpoints on challenge to contraceptive coverage mandate

NeuroVive Pharmaceutical initiates research collaboration with A1M Pharma

Agios initiates AG-120 Phase 1 study to evaluate advanced solid tumors with IDH1 mutation

New technology gives tool to examine membrane proteins in natural environment of human cell

Low dose injections of artificial properdin provide protection against septic diseases

Scientists develop new method to deliver cancer-fighting drugs directly to milk ducts

UC receives grant to better understand how "microparticles" in blood contribute to inflammation, injury

Common cholesterol-lowering drugs provide relief to patients suffering from chronic lung disease

Even while traveling overseas, Obamas are plugging health enrollment

Study: Menstrual abnormalities in women with PCOS is strongest predictor for mental health issues

New research reveals new complexity to nerve cells in brain that could affect future therapies

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy